Open AccessReal‐world outcomes of ibrutinib therapy in Korean patients with relapsed or refractory mantle cell lymphoma: a multicenter, retrospective analysis
Author(s) -
Yi Jun Ho,
Kim Seok Jin,
Yoon Dok Hyun,
Suh Cheolwon,
Chang Myung Hee,
Yang Deok Hwan,
Jo JaeCheol,
Hyun Shin Young,
Eom HyeonSeok,
Lee JeongOk,
Kwon Ji Hyun,
Han Sang Hoon,
Lee SeungShin,
Kwak JaeYong,
Kim Se Hyung,
Kim Dae Sik,
Lee Ji Hyun,
Oh Sung Yong,
Ryoo Hun Mo,
Kim Hyo Jung,
Kim Won Seog
Publication year - 2021
Publication title -
cancer communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 53
ISSN - 2523-3548
DOI - 10.1002/cac2.12150
Subject(s) - ibrutinib , mantle cell lymphoma , medicine , rituximab , oncology , bendamustine , salvage therapy , vincristine , lenalidomide , bortezomib , international prognostic index , surgery , lymphoma , chemotherapy , cyclophosphamide , leukemia , multiple myeloma , chronic lymphocytic leukemia